Supplemental material
Human Vaccines & Immunotherapeutics
Volume 18, 2022 - Issue 5
Licensed Vaccines – Research Paper
A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E’s Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator
Subhash ThuluvaClinical Development Department, Biological E Limited, Hyderabad, IndiaCorrespondence[email protected]
https://orcid.org/0000-0002-9099-420XView further author information
https://orcid.org/0000-0002-9099-420XView further author information, , , Kishore TuragaClinical Development Department, Biological E Limited, Hyderabad, Indiahttps://orcid.org/0000-0003-4197-9457View further author information
https://orcid.org/0000-0003-4197-9457View further author information &